Member Info for Kingalf

Dusty - I have decided that I've invested enough and will not chase this further. If this does realise a small percentage of its potential I'll be more than quids in, even at my current break even level.

What will be very interesting is how much new money the bods will be adding.

In addition, Vulpes Investment Management (which is controlled by Non-Executive Director Stephen Diggle), has indicated an intention to participate in the Fundraising.

If the bods are happy to participate I'm sure things aren't as dire as some on here are alluding to. Will be interesting to see how much of their own money they'll pump in, less £133k that's been announced. At least the uncertainty of a fund raise is out of the way.

Well looks like the gap between 11.18p and 10.48p going back to 25th September is about to be closed. From a technical perspective you could well see a bounce thereafter.

Let's not get too pessimistic, I'm fully on board with the excess headcount but I strongly feel that the radio silence is down to the bods working on a deal in the background. Either way we'll know the outcome in the next few months. Like the majority on here, I'm down and in my head I have written off the investment but this could literally turn

around over night. I'm staying put

Part of the reason it has dropped so much is that punters went over the top on their position, unless the results were stellar this drop was inevitable. Nothing has really changed, they still have a great product. Patience is now required.

Jiffy - I share your concerns but I'm giving the bods the benefit of the doubt and sticking to my theory that they are working on a deal in the background hence the silence. Time will tell and if nothing does materialises it will then be a major concern as to why the bulk of any fund raise is going towards paying salaries for family, friends and ex colleagues.

I can see this closing the gap at 10.5p and may as well add more when it gets to it.

All this radio silence and no bod activity when it comes to buying or selling shares reinforces my view that they are working on a deal in the background. Time will surly tell.

dug - i'm no expert and could well be completely wrong, urine does pass through the prostate via the urethra a thin tube through which urine flows from the bladder and out of the *****, and therefore has no direct contact with the prostate. i would be more convinced if they were analysing seminal fluid that the prostate does produce to produce their results.

Jiffy - Definitely a concern, but really not uncommon in this sector. Let's see what materialises in the next month or so before judging wheather they are offering shareholders value for money. Monotising the product which is what they alluded to last month is the golden goose for me and will eliminate the need to raise more funds and with the right partner could upscale this massively with all the benefits that will bring.

I'm being optimistic and put the radio silence down to the bods working on a deal.

I agree Dug, it's always a red flag but it's seems to be quite a common theme with a lot of these smaller companies, at least the bods are heavily invested which you would think would prioritise their time and efforts in OBD.

Good luck CJ39, it would be nice for a shareholder to finally make some money rather than just the bods.

I could be completely wrong, but I'm giving our CEO and fellow bods the benefit of the doubt. I think the bods will come good on this. I'm definitely not trying to ramp this up as my conviction doesn't extend to adding to my position but if only a fraction of their future potential is realised, this would be a share that you would stock up on if you had a time machine.

Seems we have a new ramper in town, sadly I see them befalling the same fate as all the others on here over the years.

our ceo could still pull this out of the bag, we only need one offer or was that bull**** as well.

time will tell.

It's now a little clearer as to why Evgen highlighted Stalicla's successful cash raise and drummed on about their partnership during the RNS last month. Maybe Huw and co had their suspicions of not getting the funds back then and thought a small reminder wouldn't go amiss, so definitely a shrewd move on their part.

It really comes down to how unscrupulous Stalicla want to be, time is definitely not on Evgen's side. They were clearly hoping a cash payout would have boosted the share price value and made a placement more palatable to existing shareholders. What we now have is a possibly expensive court proceeding that would further deplete existing reserves and in turn depreciate the share price even further. Stalicla are clearly looking to exploit Evgen's weakness and could quite easily pull the plug at this stage with the hope of picking up the spoils at a greatly reduced price from the administrators or following a very destructive share placement. One thing is for sure, they are definitely on a precipice.

I'm not expecting you to get any answers, I could be completely wrong but I feel they are working on something big in the background and confidentiality and laws governing disclosure is paramount.

ds, if true i'm shocked you would have taken such a large position, £52,000 plus by my reckoning.

i've been harping on about the risks associated with this company but clearly you don't agree.

hopefully i'm wrong and you'll hit the jackpot with this, the alternative doesn't think bear thinking about. you've certainly added a whole new dimension to ******* in the wind.

good luck, i really hope you prove me wrong and it's not borrowed money.

DS - Well I've made my opinion and views pretty clear I suppose, so going forward I'll observe from the sidelines. My final comment is BUYERS BEWARE. I will be back when these break 1p, I wouldn't want you to miss me.

Pro - maybe you could help me answer this question, they have a product in the market already, the size of the potential market is enormous, so in my eyes I could have well underestimated it.

Evgen have a product that is still at a clinical stage, hasn't been proved to work on anything yet, the trails that it was aimed at failed miserably and a set of bods who wouldn't touch the shares with a barge pole. The shares are in a constant decline, a major shareholder has just pulled out and an imminent cash call that will destroy existing shareholders value is only months away.

Stalicla is one of many that has delved into this, all the other trials failed but you suddenly expect this to miraculously deliver and change the companys fortune around over night.

Smell the coffee mate, you're just one of many who have been trying to ramp this up over the years and all ends up in the same place.